Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia

Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma Vol. 62; no. 7; pp. 1756 - 1760
Main Authors: Fodil, S., Raffoux, E., Dumas, P. Y., Desbrosses, Y., Larosa, F., Chantepie, S., Larcher, M. V., Mear, J. B., Peterlin, P., Hunault-Berger, M., Hospital, M. A., Morel, V., Lucas, N., Vidal, V., Salanoubat, C., Michel, J., Mediavilla, C., Ojeda-Uribe, M., Alexis, M., Frayfer, J., Carré, M., Maillard, N., Redjoul, R., Banos, A., Detrait, M., Cluzeau, T., Wickenhauser, S., Chaoui, D., Elassy, M., Pigneux, A., Dombret, H., Récher, C., Bertoli, S.
Format: Journal Article
Language:English
Published: United States Taylor & Francis 07-06-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1042-8194
1029-2403
DOI:10.1080/10428194.2021.1881505